Clementia Pharmaceuticals Inc. (CMTA): Price and Financial Metrics


Clementia Pharmaceuticals Inc. (CMTA): $26.35

-0.03 (-0.11%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

CMTA Stock Price Chart Interactive Chart >

Price chart for CMTA

CMTA Price/Volume Stats

Current price $26.35 52-week high $26.73
Prev. close $26.38 52-week low $8.10
Day low $26.28 Volume 716,700
Day high $26.69 Avg. volume 204,154
50-day MA $23.18 Dividend yield N/A
200-day MA $14.63 Market Cap 1.00B

Clementia Pharmaceuticals Inc. (CMTA) Company Bio


Clementia Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops disease-modifying treatments for patients suffering from debilitating bone and other diseases. Its lead product candidate is palovarotene, an oral small molecule that binds and activates retinoic acid receptor gamma, and prevents abnormal new bone formation, as well as scar tissue formation in various tissues in animal models. The company is developing palovarotene for the treatment of fibrodysplasia ossificans progressiva and multiple osteochondroma, as well as has one Phase III and Phase II/III trials for two separate indications. Clementia Pharmaceuticals Inc. was founded in 2010 and is based in Montreal, Canada.


CMTA Latest News Stream


Event/Time News Detail
Loading, please wait...

CMTA Latest Social Stream


Loading social stream, please wait...

View Full CMTA Social Stream

CMTA Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6628 seconds.